Skip to content
2000
Volume 27, Issue 20
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background: LncRNA is a kind of non-coding RNA and its research is more popular in recent years, which has more than 200 nucleotides. It plays a significant part in various biological functions, including chromosome modification, genome modification, transcriptional activation, transcriptional interference, and other processes. FTX, at the center of the X chromosome inactivation and it has been shown that lncRNA FTX regulates cancer cells’ development, migration, and invasion in many studies. Methods: Relevant literature was collected through the PubMed system search and is summarized in this article. Results: LncRNA FTX abnormally increased in tumor cells, such as liver cancer, stomach cancer, leukemia, renal cell carcinoma, colorectal cancer, glioma, osteosarcoma, etc. However, the expression level decreased in temporal lobe epilepsy, liver cirrhosis, heart failure, etc. Conclusion: FTX may be an important regulatory factor and a potential therapeutic target in cancers.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666201029164036
2021-06-01
2025-04-04
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666201029164036
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; cirrhosis; heart failure; LncRNA FTX; osteosarcoma; temporal lobe epilepsy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test